• 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

9G2 Share Price Performance

S$0.048
0.01 (29.73%)
S$0.048
0.01 (29.73%)
Price S$0.048

9G2 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Moderate risk with weak fundamentals.

5 Risks
0 Rewards

Singapore Institute of Advanced Medicine Holdings Ltd. Key Details

S$15.9m

Revenue

S$8.8m

Cost of Revenue

S$7.2m

Gross Profit

S$33.2m

Other Expenses

-S$26.0m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
-0.021
45.02%
-163.36%
51.0%
View Full Analysis

About 9G2

Founded
2011
Employees
n/a
CEO
Shih Kien Djeng
WebsiteView website
www.advancedmedicine.sg

Singapore Institute of Advanced Medicine Holdings Ltd., an investment holding company, provides medical diagnostics and treatments, and radiation therapy and medical oncology services in Singapore. The company offers medical diagnostics and treatments, including cancer-related diagnostics and theragnostic treatments, general diagnostics and health screening, and aesthetic services; and radiation therapy and medical oncology services comprise proton beam therapy, photon radiation therapy, and medical oncology services. It provides clinic and imaging services; manufactures medical research and clinical diagnostic instruments and supplies; and sells pharmaceuticals, surgical products, and consumables. Singapore Institute of Advanced Medicine Holdings Ltd. was incorporated in 2011 and is based in Singapore.

Recent 9G2 News & Updates

Recent updates

No updates